Literature DB >> 23376915

Fecal microbiota transplantation for recurrent C difficile infection: ready for prime time?

Markus D Agito1, Ashish Atreja, Maged K Rizk.   

Abstract

Recurrent Clostridium difficile infection has been a major challenge for patients and clinicians. Recurrence of infection after treatment with standard antibiotics is becoming more common with the emergence of more-resistant strains of C difficile. Fecal microbiota transplantation is an alternative treatment for recurrent C difficile infection, but it is not yet widely used.

Entities:  

Mesh：

Year:  2013        PMID： 23376915     DOI： 10.3949/ccjm.80a.12110

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  6 in total

1.  Using a Novel Lysin To Help Control Clostridium difficile Infections.

Authors:  Qiong Wang; Chad W Euler; Aurelia Delaune; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report.

Authors:  J-C Lagier; M Delord; M Million; P Parola; A Stein; P Brouqui; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-07       Impact factor: 3.267

3.  Probiotics for the treatment of Clostridium difficile associated disease.

Authors:  Leo R Fitzpatrick
Journal:  World J Gastrointest Pathophysiol       Date:  2013-08-15

4.  Chinese physicians' perceptions of fecal microbiota transplantation.

Authors:  Rong-Rong Ren; Gang Sun; Yun-Sheng Yang; Li-Hua Peng; Shu-Fang Wang; Xiao-Hong Shi; Jing-Quan Zhao; Yong-Ling Ban; Fei Pan; Xue-Hong Wang; Wei Lu; Jian-Lin Ren; Ying Song; Jiang-Bin Wang; Qi-Ming Lu; Wen-Yuan Bai; Xiao-Ping Wu; Zi-Kai Wang; Xiao-Mei Zhang; Ye Chen
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

5.  Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.

Authors:  Bruce E Hirsch; Nimit Saraiya; Kaitlin Poeth; Rebecca M Schwartz; Marcia E Epstein; Gerard Honig
Journal:  BMC Infect Dis       Date:  2015-04-17       Impact factor: 3.090

Review 6.  Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides.

Authors:  Mihai Covasa; Richard W Stephens; Roxana Toderean; Claudiu Cobuz
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-19       Impact factor: 5.555
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.